Compare IT PEOPLE (INDIA) with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

COMMEX TECHNOLOGY vs INDOCO REMEDIES - Comparison Results

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    COMMEX TECHNOLOGY INDOCO REMEDIES COMMEX TECHNOLOGY/
INDOCO REMEDIES
 
P/E (TTM) x -0.0 128.4 - View Chart
P/BV x 0.1 2.2 2.6% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 COMMEX TECHNOLOGY   INDOCO REMEDIES
EQUITY SHARE DATA
    COMMEX TECHNOLOGY
Mar-17
INDOCO REMEDIES
Mar-18
COMMEX TECHNOLOGY/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs2317 0.5%   
Low Rs1178 0.3%   
Sales per share (Unadj.) Rs0113.1 0.0%  
Earnings per share (Unadj.) Rs-4.64.5 -102.3%  
Cash flow per share (Unadj.) Rs-4.511.8 -38.4%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs3.473.2 4.6%  
Shares outstanding (eoy) m155.1192.15 168.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio xNM2.2-  
Avg P/E ratio x-0.355.5 -0.5%  
P/CF ratio (eoy) x-0.321.0 -1.2%  
Price / Book Value ratio x0.33.4 10.1%  
Dividend payout %022.4 0.0%   
Avg Mkt Cap Rs m17822,830 0.8%   
No. of employees `000NA5.5 0.0%   
Total wages/salary Rs m32,209 0.1%   
Avg. sales/employee Rs ThNM1,910.1-  
Avg. wages/employee Rs ThNM405.0-  
Avg. net profit/employee Rs ThNM75.5-  
INCOME DATA
Net Sales Rs m010,419 0.0%  
Other income Rs m1347 26.7%   
Total revenues Rs m1310,466 0.1%   
Gross profit Rs m-591,349 -4.4%  
Depreciation Rs m5677 0.7%   
Interest Rs m0235 0.0%   
Profit before tax Rs m-51484 -10.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-6580-   
Tax Rs m072 0.0%   
Profit after tax Rs m-709412 -172.2%  
Gross profit margin %NM12.9- 
Effective tax rate %015.0 0.0%   
Net profit margin %NM4.0- 
BALANCE SHEET DATA
Current assets Rs m3335,373 6.2%   
Current liabilities Rs m284,157 0.7%   
Net working cap to sales %NM11.7- 
Current ratio x11.81.3 915.5%  
Inventory Days DaysNM68- 
Debtors Days DaysNM73- 
Net fixed assets Rs m2166,244 3.5%   
Share capital Rs m338184 183.5%   
"Free" reserves Rs m1836,566 2.8%   
Net worth Rs m5216,750 7.7%   
Long term debt Rs m01,233 0.0%   
Total assets Rs m54912,363 4.4%  
Interest coverage xNM3.1-  
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x00.8 0.0%   
Return on assets %-129.15.2 -2,467.3%  
Return on equity %-136.16.1 -2,231.6%  
Return on capital %-136.19.0 -1,510.6%  
Exports to sales %NM0-  
Imports to sales %NM0-  
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m03,762 0.0%   
Fx outflow Rs m01,143 0.0%   
Net fx Rs m02,619 0.0%   
CASH FLOW
From Operations Rs m-1921,227 -15.6%  
From Investments Rs m192-1,360 -14.1%  
From Financial Activity Rs mNA-388 0.0%  
Net Cashflow Rs m0-521 -0.0%  

Share Holding

Indian Promoters % 38.4 59.2 64.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 12.5 0.2%  
FIIs % 21.5 6.0 358.3%  
ADR/GDR % 4.8 0.0 -  
Free float % 35.4 22.4 158.0%  
Shareholders   20,783 12,805 162.3%  
Pledged promoter(s) holding % 75.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare COMMEX TECHNOLOGY With:   GREENPLY INDUSTRIES  STC INDIA  FINOLEX INDUSTRIES  INDIABULLS FIN. SER.  INGERSOLL RAND  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

INDOCO REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 76.4% (Quarterly Result Update)

Jan 24, 2019 | Updated on Jan 24, 2019

For the quarter ended December 2018, INDOCO REMEDIES has posted a net profit of Rs 53 m (down 76.4% YoY). Sales on the other hand came in at Rs 3 bn (down 5.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

COMMEX TECHNOLOGY SHARE PRICE


Sep 19, 2019 (Close)

TRACK COMMEX TECHNOLOGY

  • Track your investment in COMMEX TECHNOLOGY with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON COMMEX TECHNOLOGY

COMMEX TECHNOLOGY - BAJAJ FINANCE COMPARISON

COMPARE COMMEX TECHNOLOGY WITH

MARKET STATS